Ludura Soft Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Ludura Soft Cream is effective against a broad spectrum of dermatophytes, yeasts, and molds. The cream formulation allows for easy application and rapid absorption into the affected skin areas, providing symptomatic relief from itching, redness, and scaling. It is typically applied once daily to the clean, dry affected area for a duration determined by the severity and type of infection, usually ranging from one to four weeks. Ludura Soft Cream is generally well tolerated, with minimal local adverse effects such as mild burning, irritation, or erythema reported infrequently. It is contraindicated in patients with known hypersensitivity to Luliconazole or any of the cream’s excipients. Caution is advised when applying near mucous membranes or broken skin. Ludura Soft Cream should be used under medical supervision, ensuring adherence to prescribed treatment duration to prevent recurrence or resistance.